Pneumocystis carinii

Improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.)

Marilyn S. Bartlett, Jay A. Fishman, Michelle M. Durkin, Sherry Queener, James W. Smith

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Rats which were immunosuppressed with adrenal corticosteroids then transtracheally inoculated with Pneumocystis carinii were evaluated as models for study of drug efficacy. Trimethoprim/sulfamethoxazole, known to be effective against Pneumocystis, was given in therapeutic and prophylactic regimens and its long-term effectiveness determined by a protocol to study relapse. Untreated animals uniformly developed severe infection with differences in numbers of organisms between untreated and treated animals being greater than two logs. Therapy or prophylaxis studies could be completed in 6 to 7 weeks. Animals given prophylaxis or therapy with trimethoprim/sulfamethoxazole had few organisms detected in lungs. Numbers of organisms did not increase during the 4 weeks when the animals were continued on immunosuppression after discontinuing treatment as long as reinfection was prevented. These models are useful for evaluating anti-Pneumocystis activity of antimicrobials. Relapse study data suggest that reinfection may have an important role in development of recurrent Pneumocystis pneumonia.

Original languageEnglish
Pages (from-to)100-106
Number of pages7
JournalExperimental Parasitology
Volume70
Issue number1
DOIs
StatePublished - 1990

Fingerprint

Pneumocystis carinii
Pneumocystis Pneumonia
Pneumocystis
Sulfamethoxazole Drug Combination Trimethoprim
Pharmaceutical Preparations
Recurrence
Therapeutics
Immunosuppression
Adrenal Cortex Hormones
Lung
Infection

Keywords

  • Animal model
  • Pneumocystis carinii
  • Pneumonia
  • Prophylaxis
  • Relapse
  • Therapy

ASJC Scopus subject areas

  • Immunology
  • Parasitology
  • Infectious Diseases

Cite this

Pneumocystis carinii : Improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). / Bartlett, Marilyn S.; Fishman, Jay A.; Durkin, Michelle M.; Queener, Sherry; Smith, James W.

In: Experimental Parasitology, Vol. 70, No. 1, 1990, p. 100-106.

Research output: Contribution to journalArticle

@article{e177fedbcae54e7bb91f08a4eddb080b,
title = "Pneumocystis carinii: Improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.)",
abstract = "Rats which were immunosuppressed with adrenal corticosteroids then transtracheally inoculated with Pneumocystis carinii were evaluated as models for study of drug efficacy. Trimethoprim/sulfamethoxazole, known to be effective against Pneumocystis, was given in therapeutic and prophylactic regimens and its long-term effectiveness determined by a protocol to study relapse. Untreated animals uniformly developed severe infection with differences in numbers of organisms between untreated and treated animals being greater than two logs. Therapy or prophylaxis studies could be completed in 6 to 7 weeks. Animals given prophylaxis or therapy with trimethoprim/sulfamethoxazole had few organisms detected in lungs. Numbers of organisms did not increase during the 4 weeks when the animals were continued on immunosuppression after discontinuing treatment as long as reinfection was prevented. These models are useful for evaluating anti-Pneumocystis activity of antimicrobials. Relapse study data suggest that reinfection may have an important role in development of recurrent Pneumocystis pneumonia.",
keywords = "Animal model, Pneumocystis carinii, Pneumonia, Prophylaxis, Relapse, Therapy",
author = "Bartlett, {Marilyn S.} and Fishman, {Jay A.} and Durkin, {Michelle M.} and Sherry Queener and Smith, {James W.}",
year = "1990",
doi = "10.1016/0014-4894(90)90089-U",
language = "English",
volume = "70",
pages = "100--106",
journal = "Experimental Parasitology",
issn = "0014-4894",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Pneumocystis carinii

T2 - Improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.)

AU - Bartlett, Marilyn S.

AU - Fishman, Jay A.

AU - Durkin, Michelle M.

AU - Queener, Sherry

AU - Smith, James W.

PY - 1990

Y1 - 1990

N2 - Rats which were immunosuppressed with adrenal corticosteroids then transtracheally inoculated with Pneumocystis carinii were evaluated as models for study of drug efficacy. Trimethoprim/sulfamethoxazole, known to be effective against Pneumocystis, was given in therapeutic and prophylactic regimens and its long-term effectiveness determined by a protocol to study relapse. Untreated animals uniformly developed severe infection with differences in numbers of organisms between untreated and treated animals being greater than two logs. Therapy or prophylaxis studies could be completed in 6 to 7 weeks. Animals given prophylaxis or therapy with trimethoprim/sulfamethoxazole had few organisms detected in lungs. Numbers of organisms did not increase during the 4 weeks when the animals were continued on immunosuppression after discontinuing treatment as long as reinfection was prevented. These models are useful for evaluating anti-Pneumocystis activity of antimicrobials. Relapse study data suggest that reinfection may have an important role in development of recurrent Pneumocystis pneumonia.

AB - Rats which were immunosuppressed with adrenal corticosteroids then transtracheally inoculated with Pneumocystis carinii were evaluated as models for study of drug efficacy. Trimethoprim/sulfamethoxazole, known to be effective against Pneumocystis, was given in therapeutic and prophylactic regimens and its long-term effectiveness determined by a protocol to study relapse. Untreated animals uniformly developed severe infection with differences in numbers of organisms between untreated and treated animals being greater than two logs. Therapy or prophylaxis studies could be completed in 6 to 7 weeks. Animals given prophylaxis or therapy with trimethoprim/sulfamethoxazole had few organisms detected in lungs. Numbers of organisms did not increase during the 4 weeks when the animals were continued on immunosuppression after discontinuing treatment as long as reinfection was prevented. These models are useful for evaluating anti-Pneumocystis activity of antimicrobials. Relapse study data suggest that reinfection may have an important role in development of recurrent Pneumocystis pneumonia.

KW - Animal model

KW - Pneumocystis carinii

KW - Pneumonia

KW - Prophylaxis

KW - Relapse

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0025191262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025191262&partnerID=8YFLogxK

U2 - 10.1016/0014-4894(90)90089-U

DO - 10.1016/0014-4894(90)90089-U

M3 - Article

VL - 70

SP - 100

EP - 106

JO - Experimental Parasitology

JF - Experimental Parasitology

SN - 0014-4894

IS - 1

ER -